Sentiss Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SENTISS PHARMA
SENTISS PHARMA has one approved drug.
Drugs and US Patents for Sentiss Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sentiss Pharma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217195-001 | May 8, 2023 | AT3 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

